Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05760794 · ClinicalTrials.gov registry record · NA
Barbed-suture Efficiency Study for Sacrocolpopexy
A NA study of Prolapse; Female, sponsored by Wake Forest University Health Sciences.
- Active
- Registry status
- NA
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT05760794: Active NA study of Prolapse; Female, sponsored by Wake Forest University Health Sciences.
NCT05760794 is a NA study of Prolapse; Female that is active but no longer recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 52 participants, below the 145-participant average among 3 other Prolapse; Female trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05760794, a NA study of Prolapse; Female, is active but no longer recruiting, sponsored by Wake Forest University Health Sciences.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
Minimally invasive sacrocolpopexy (SCP) performed laparoscopically or with robotic assistance is associated with improved patient-centered outcomes such as faster recovery times, less pain, less bleeding, and shorter hospital stay, however at the expense of longer operating times. One of the time consuming parts of the procedure is vaginal mesh attachment.
Primary Outcome
To determine if delayed-absorbable barbed suture (2-0 V-Loc) produces a decrease in the time to achieve vaginal mesh attachment during minimally invasive SCP (with or without concomitant total hysterectomy) compared to delayed- absorbable polydioxanone (2-0 PDS) interrupted suture - time (in minutes and seconds)
Conditions Studied
Interventions
- PROCEDURE Non-barbed delayed absorbable suture
- PROCEDURE Barbed delayed absorbable suture
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2023-06-21 |
| Est. Completion | 2027-12 |
| Phase | NA |
What the registry record for NCT05760794 still lists
NCT05760794 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 145-participant average among 3 other Prolapse; Female trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Prolapse; Female appearing as the primary indexed condition, and to 2 interventions - of which Non-barbed delayed absorbable suture is the first listed.
NCT05760794 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05760794 about?
NCT05760794 is a clinical study titled "Barbed-suture Efficiency Study for Sacrocolpopexy". Minimally invasive sacrocolpopexy (SCP) performed laparoscopically or with robotic assistance is associated with improved patient-centered outcomes such as faster recovery times, less pain, less bleeding, and shorter hospital stay, however at the expense of longer operating times. One of the time co...
What is the current status of trial NCT05760794?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 52 participants. The study started on 2023-06-21. Estimated completion is 2027-12.
What conditions does trial NCT05760794 study?
This clinical trial studies the following conditions: Prolapse; Female.
What interventions are being tested in trial NCT05760794?
The interventions under investigation include: Non-barbed delayed absorbable suture (PROCEDURE), Barbed delayed absorbable suture (PROCEDURE).
Who is sponsoring clinical trial NCT05760794?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05760794 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prolapse; Female
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI